| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |